Arteriographic demonstration of slow antegrade opacification distal to a cerebrovascular thromboembolic occlusion site as a favorable indicator for intra-arterial thrombolysis

American Journal of Neuroradiology

Volumn 27, Issue 7, 2006, Pages 1528-1531

  Christoforidis, Gregory A ^a   Mohammad, Y ^a   Avutu, B ^a   Tejada, A ^a   Slivka, A P ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT; GLUCOSE; PROUROKINASE; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; BRAIN ANGIOGRAPHY; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; OCCLUSIVE CEREBROVASCULAR DISEASE; PIA MATER; RECANALIZATION; SCORING SYSTEM; SYSTOLIC BLOOD PRESSURE; THROMBOCYTE;

AGE FACTORS; AGED; BLOOD GLUCOSE; BLOOD PRESSURE; CEREBRAL ANGIOGRAPHY; CEREBRAL ARTERIES; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR CIRCULATION; COLLATERAL CIRCULATION; CONTRAST MEDIA; FEMALE; FIBRINOLYTIC AGENTS; FORECASTING; HUMANS; INJECTIONS, INTRA-ARTERIAL; INTRACRANIAL EMBOLISM; INTRACRANIAL THROMBOSIS; MALE; RETROSPECTIVE STUDIES; THROMBOLYTIC THERAPY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME; URINARY PLASMINOGEN ACTIVATOR;

EID: 33747452433     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Del Zoppo G, Higashida R, Furlan A, et al. PROACT: A Phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke 1998;29:4-11
2. Furlan A, Higashida R, Weschler L, et al. Intra-arterial prourokinase for acute ischemic stroke: the PROACT II study. JAMA 1999;282:2003-11
3. Christoforidis GA, Mohammad Y, Kehagias D, et al. Angiographic assessment of pial collaterals as a prognostic indicator following intra-arterial thrombolysis for acute ischemic stroke. AJNR Am J Neuroradiol 2005;26:1789-97
4. Zeumer H, Freitag HJ, Zanella F, et al. Local intra-arterial fibrinolytic therapy in patients with stroke: urokinase versus recombinant tissue plasminogen activator (r-TPA). Neuroradiology 1993;35:159-62
5. Suarez J, Sunshine J, Tarr R, et al. Predictors of clinical improvement, angiographic recanalization, and intracranial hemorrhage after intra-arterial thrombolysis for acute ischemic stroke. Stroke 1999;30:2094-100
6. Kucinski T, Koch C, Eckert B, et al. Collateral circulation is an independent radiological predictor of outcome after thrombolysis in acute ischaemic stroke. Neuroradiology 2003;45:11-18
7. Pillai JJ, Lanzier CF, Trinidad SB, et al. Initial angiographic appearance of intracranial vascular occlusions in acute stroke as a predictor of outcome of thrombolysis: initial experience. Radiology 2001;218:733-38
8. Morris P. Practical neuroangiography. Baltimore: Williams and Wilkins; 1997: 87-278
9. The Thrombolysis in Myocardial Infarction (TIMI) trial: Phase I findings: TIMI Study Group. N Engl J Med 1985;312:932-36
10. Von Kummer R, Holle R, Rosin L, et al. Does arterial recanalization improve outcome in carotid territory stroke? Stroke 1995;26:581-87
11. Sorimachi T, Fujii Y, Tsuchiya N, et al. Recanalization by mechanical embolus disruption during intra-arterial thrombolysis in the carotid territory. AJNR Am J Neuroradiol 2004;25:1391-402
12. The National Institute of Neurological Disorders and Stroke (NINDS) trial. N Engl J Med 1995;33:1581-87
13. Clark WM, Wissman S, Albers GW, et al. Recombinant tissue-type plasminogen activator (alpteplase) for ischemic stroke 3 to 5 hours after symptom onset: the ATLANTIS study. JAMA 1999;282:2019-26
14. Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: the european cooperative acute stroke study (ECASS). JAMA 1995;274:1017-25
15. Del Zoppo G, Poeck K, Pessin M, et al. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol 1992;32:78-86
16. Von Kummer R, Hacke W. Safety and efficacy of intravenous tissue plasminogen activator and heparin in acute middle cerebral artery stroke. Stroke 1992; 23:646-52
17. Levy D, Brott T, Haley C, et al. Factors related to intracranial hematoma formation in patients receiving tissue-type plasminogen activator for acute ischemic stroke. Stroke 1994;25:291-97
18. Jaillard A, Cornu C, Durieux A. Hemorrhagic transformation in acute ischemic stroke: the MAST-E study. Stroke 1999;30:1326-32
19. Larrue V, von Kummer R, del Zoppo G, et al. Hemorrhagic transformation in acute ischemic stroke potential contributing factors in the european cooperative acute stroke study. Stroke 1997;28:957-60
20. Demchuk A, Morgenstern L, Krieger D, et al. Serum glucose level and diabetes predict tissue plasminogen activator-related intracerebral hemorrhage in acute ischemic stroke. Stroke 1999;30:34-39
21. Kase C, Furlan AJ, Weschler L, et al. Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke: The PROACT II Trial. Neurology 2001;57
22. Hacke W, Kaste M, Fieschi C, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). The Lancet 1998;353:1245-51
23. Weir C, Murray G, Dyker A, et al. Is hyperglycemia an independent predictor of poor outcome after acute stroke:Results of a long term follow up study. BMJ 1997;314:1303-06
24. Kidwell CS, Saver JL, Carnado J, et al. Predictors of hemorrhagic transformation in patients receiving intra-arterial thrombolysis. Stroke 2002;33:717
25. Yip HK, Chen MC, Chang HW, et al. Angiographic morphologic features of infarct-related arteries and timely reperfusion in acute myocardial infarction: predictors of slow-flow and no-reflow phenomenon. Chest 2002;122:1322-32